Physician profile
Kenneth B Smith
NPI 1356310650
$4,378.40
in general payments reported to CMS, 2019-2025
28 companies · $154 in 2025
The $154 reported for 2025 was more than what a typical Hospice and Palliative Medicine (Internal Medicine) provider received nationally (typical 2025 total: $77.77).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,110 · 2020: $708 · 2021: $833 · 2022: $978 · 2023: $546 · 2024: $49.59 · 2025: $154.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $750.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $749.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $942.14 | 2019-2023 | Tezspire, Fasenra |
| Glaxosmithkline, LLC. | $904.02 | 2019-2023 | Trelegy Ellipta, Nucala |
| Boehringer Ingelheim Pharmaceuticals, INC. | $450.23 | 2019-2024 | Jardiance, Ofev |
| Sunovion Pharmaceuticals INC. | $316.54 | 2019-2020 | |
| Regeneron Healthcare Solutions, INC. | $297.88 | 2019-2023 | Dupixent |
| Actelion Pharmaceuticals US, INC. | $163.63 | 2019-2023 | Uptravi |
| Grifols USA, LLC | $151.50 | 2020-2023 | Prolastin-C Liquid |
| Mylan Specialty L.P. | $123.96 | 2021-2023 | Yupelri |
| Novartis Pharmaceuticals Corporation | $119.30 | 2020-2025 | |
| United Therapeutics Corporation | $109.84 | 2019-2023 | Tyvaso |
| Bayer Healthcare Pharmaceuticals INC. | $109.82 | 2021-2023 | |
| Amgen INC. | $97.09 | 2022 | |
| Genentech USA, INC. | $74.85 | 2019 | |
| Scpharmaceuticals INC. | $70.03 | 2024-2025 | |
| Genzyme Corporation | $60.04 | 2022-2023 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $57.89 | 2022 | |
| Csl Behring | $38.69 | 2020 | |
| Electromed, INC. | $36.69 | 2022 | |
| Inogen, INC. | $36.21 | 2023 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| E.R. Squibb & Sons, L.L.C. | $35.32 | 2019-2020 | |
| Ethicon INC. | $31.26 | 2022 | |
| Philips North America LLC | $30.00 | 2023 | |
| Janssen Pharmaceuticals, INC | $24.96 | 2021 | |
| Inari Medical, INC. | $24.49 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Gilead Sciences, INC. | $24.25 | 2021 | |
| Paratek Pharmaceuticals, INC. | $19.40 | 2022 | |
| Insmed, INC. | $15.40 | 2019 | |
| Circassia INC. | $12.97 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kenneth Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.